• Voicu Groza (University of Ottawa, School of Information Technology and Engineering)
  • Wayne K. Hindmarsh (University of Toronto, Leslie Dan Faculty of Pharmacy)
  • Radu Leca (Biosign Technologies)
  • George Mihalas (European Federation of Medical Informatics)
  • Tofy Mussivand (Ottawa Heart Institute) – Chair
  • David Silver (Johns Hopkins Applied Physics Laboratories)
  • Sreeraman Rajan (Defence R&D Canada-Ottawa)


  • Wahab Almuhtadi (IEEE Ottawa Section Chair; Algonquin College, Faculty of Technology and Trades)
  • Branislav Djokic (National Research Council of Canada, Institute for National Measurement Standards)
  • Rafik Goubran (Carleton University, Faculty of Engineering and Design)
  • Voicu Groza (University of Ottawa, School of Information Technology and Engineering)
  • Radu Leca (Biosign Technologies)


  • Raed Abdullah (Chair)
  • Bogdan Groza (Local Arrangements)
  • Radu Leca (Sponsorship)
  • Khalid Mahmood (Publicity)
  • Sreeraman Rajan (Treasurer)
  • Preeti Raman (Registration)

Workshop Philosophy

  • Premise
    • Modern health care demands more efficient means of monitoring adverse events than statistical speculation on anecdotal evidence. Spontaneous reporting systems, composed largely of anecdotal case reports, are currently the cornerstone of safety signal detection. As a result, less than 3% of publications deal with medication-related illness.
  • Objective
    • In a bid to advance patient safety science and technology, the workshop will provide a non-commercial, international forum for addressing the "hard problem" in health care (capturing and processing safety signals at the source) towards engineering a framework for prompt and objective monitoring of adverse events, regardless of location.
  • Motivation
    • The instrumentation and measurement issues related to medication errors and adverse events are still poorly understood. The ongoing debates on the applicability of scientific principles to patient safety have not provided a framework for understanding measurement issues.
  • Ways
    • Safety signals are generated biologically. The patient is the only source of real information. The radical uncertainty of the response to medication demands that patients are monitored by objective means to quality-assure the production of data at the source.
  • Means
    • Standard on adverse response measurement and analysis by objectve techniques: the need for such a standard has become imperative in view of the rapid industrialization of health care.